Zucker Hillside Hospital

Northwell Launches $500 Million Initiative to Expand Pediatric Mental Health Services and Access to Care for Children and Teens

Retrieved on: 
星期三, 十一月 8, 2023
Managed Care, Family, Philanthropy, Consumer, Mental Health, Hospitals, Teens, Fund Raising, Parenting, Children, Practice Management, Health, Mental, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Adolescence, Ageing, Education, Cohen, Korea Disease Control and Prevention Agency, Impossible, Zucker Hillside Hospital, MD, Hofstra University, Psychiatry, Island, Mental health, Research, Multimedia, Pediatrics, Donald, Disorder, Student, Hospital, Stigma, Blumenfeld, Suicide, Depression, Citi Field, Anxiety, Patient, Bed, Death, Transplant, Parent, Nursing, Northwell Health, Child

The future Child and Adolescent Mental Health Pavilion will be connected to Cohen Children’s Medical Center and Zucker Hillside Hospital , Northwell’s adult mental health facility, in Queens, NY.

Key Points: 
  • The future Child and Adolescent Mental Health Pavilion will be connected to Cohen Children’s Medical Center and Zucker Hillside Hospital , Northwell’s adult mental health facility, in Queens, NY.
  • The approximately 200,000-square-foot building will fully integrate physical and mental health care for children and serve as a destination program for patients across the country.
  • The initiative will bring together Northwell’s extensive expertise in children’s clinical care, mental health, leading-edge research, education and medical training to set a new standard for care.
  • This investment will break the archaic siloed approach in which physical health is addressed at one facility and mental health at another by fully integrating physical and mental health care for children.”
    Through Cohen Children’s Medical Center, Northwell currently operates pediatric behavioral health urgent care centers in Nassau and Suffolk counties.

Feinstein Institutes Awarded $6.1M to Fund Bipolar Disorder Patient and Research Hub

Retrieved on: 
星期四, 十月 19, 2023
Mental Health, Health, Biometrics, Clinical Trials, Research, Science, Biotechnology, Knowledge, Patient, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Medical research, Feinstein, Feinstein Institutes for Medical Research, Transcranial magnetic stimulation, Johns Hopkins University, Zucker Hillside Hospital, Hofstra University, Psychiatry, Bipolar disorder, Multimedia, Donald, Clinical trial, Schizophrenia, Institutional review board, Behavioural sciences, Credit, University, Magnetic resonance imaging, University of California, Los Angeles, BD2, University of Michigan, Hospital, BSN, Mayo Clinic, Pharmaceutical industry, MD, Brigham, Wellcome

Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.

Key Points: 
  • Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.
  • Through a national research grant and innovative networking system aimed to connect patients to care, it might become easier for people with bipolar disorder to find new treatments and clinical trials.
  • (Credit: Feinstein Institutes)
    Researchers at The Feinstein Institutes for Medical Research received a $6.1 million grant from Breakthrough Discoveries for Thriving with Bipolar Disorders Foundation (BD2) to serve as a hub of six other sites across the country.
  • “Although bipolar disorder impacts millions of Americans every year, it is under-researched,” said Kevin J. Tracey, MD , president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research.

Novel investigational postpartum depression pill showed rapid and significant improvement in depressive symptoms in Phase 3 clinical trial

Retrieved on: 
星期三, 七月 26, 2023
Mental Health, Research, Women, Clinical Trials, Health Insurance, Health, Consumer, Pharmaceutical, Science, GABA, PPD, Perseverance, JAMA, Depression, Diarrhea, NAS, Feinstein Institutes for Medical Research, Somnolence, COVID-19, Food and Drug Administration, Clinical trial, Urinary tract infection, Woman, DSM-IV codes, Multimedia, The American Journal of Psychiatry, Mother, American Medical Association, American Journal, Behavioural sciences, Dizziness, Journal, Patient, Zucker Hillside Hospital, Zuranolone, Grammatical mood, Nausea, Paper, FDA, Headache, Credit, Northwell Health, Safety, Medical research, Food, Female, Pharmaceutical industry, Birth control, MD, Psychiatry

Fourteen-day oral, at-home, treatment with zuranolone versus placebo resulted in statistically significant improvement in depressive symptoms, as measured by change from baseline in HAMD-17 total score.

Key Points: 
  • Fourteen-day oral, at-home, treatment with zuranolone versus placebo resulted in statistically significant improvement in depressive symptoms, as measured by change from baseline in HAMD-17 total score.
  • Results showed that 57 percent of the women taking zuranolone versus 38 percent of women taking placebo experienced a 50 percent or more improvement in their depressive symptoms at day 15.
  • The trial demonstrated the improvement in depressive symptoms with zuranolone at 30 mg versus placebo in patients with PPD and that zuranolone was generally well tolerated.
  • The SKYLARK and ROBIN clinical trials provide some of the most substantial results for improving depressive symptoms in women with PPD.

Silver Hill Hospital Names Dr. Mark J. Russ as Chief Medical Officer

Retrieved on: 
星期二, 七月 25, 2023
General Health, Hospitals, Health, Lewis Steward House, American Psychiatric Association, Montefiore Medical Center, Haverford College, Silver Hill Hospital, COVID-19, Drexel University College of Medicine, Multimedia, Pharmacy, Associate, Aggression, Medical director, Patient, School, Yale New Haven Health System, Zucker Hillside Hospital, Psychiatry, Growth, Mental health, Weill Cornell Medicine, Nursing, Hospital

Silver Hill Hospital , one of the nation’s premier psychiatric hospitals, has named Dr. Mark J. Russ , as Chief Medical Officer to oversee clinical operations of its inpatient, transitional living (residential), and outpatient programs.

Key Points: 
  • Silver Hill Hospital , one of the nation’s premier psychiatric hospitals, has named Dr. Mark J. Russ , as Chief Medical Officer to oversee clinical operations of its inpatient, transitional living (residential), and outpatient programs.
  • View the full release here: https://www.businesswire.com/news/home/20230725458122/en/
    Dr. Mark J. Russ, Chief Medical Officer at Silver Hill Hospital (Photo: Business Wire)
    Russ has deep experience in the psychiatric care of complex patients as well as in hospital administration.
  • He joins Silver Hill Hospital from New York-Presbyterian/Westchester Behavioral Health, where he served as Vice Chair for Clinical Programs and Medical Director for the past eight years.
  • Russ has an extensive background and reputation for driving innovation, facilitating growth, and improving psychiatric care,” said Andrew Gerber, M.D., Ph.D., President and Medical Director of Silver Hill Hospital.

Northwell Named a Leader in LGBTQ+ Health Care

Retrieved on: 
星期二, 三月 29, 2022
LGBTQ+, Health, Consumer, Hospitals, Other Health, General Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Human Rights Campaign, Rehabilitation, Hospital, Medicine, Workforce, MD, Center, Twitter, Feinstein Institute for Medical Research, Trust, Nursing, Lenox Health Greenwich Village, Health, Northern Westchester Hospital, Zucker Hillside Hospital, Phelps Memorial Hospital, Long Island Jewish Medical Center, Multimedia, Medical Center, Lenox Hill Hospital, Medical research, Long Island Jewish Forest Hills, Equity, Glen Cove Hospital, Instagram, Patient, Health equity, LinkedIn, Yugoslavia–European Communities relations, Leadership, Staten Island University Hospital, Teaching hospital, HEI, Physician, Employee resource group, Northwell Health, Facebook

Northwell Health has been recognized as a national leader in lesbian, gay, bisexual, transgender and queer (LGBTQ+) inclusiveness by the 2022 Healthcare Equality Index (HEI).

Key Points: 
  • Northwell Health has been recognized as a national leader in lesbian, gay, bisexual, transgender and queer (LGBTQ+) inclusiveness by the 2022 Healthcare Equality Index (HEI).
  • Credit Northwell Health
    Twenty-five Northwell facilities earned Equity Leader status, which is based on the health systems policies and practices dedicated to the equitable treatment and inclusion of LGBTQ+ patients, staff and visitors.
  • Northwell Health-GoHealth Urgent Care, which operates more than 50 locations in the New York Metro area, earned top performer status.
  • Our 78,000 employees 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners are working to change health care for the better.

Northwell Health Donates Vital Supplies to Aid Ukraine

Retrieved on: 
星期五, 三月 4, 2022
Fund Raising, Hospitals, Health, Other Philanthropy, Philanthropy, Atmosphere, United Nations, Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Staten Island University Hospital, Twitter, Government, Instagram, LinkedIn, Friends, Multimedia, MSN, Nursing, Zucker Hillside Hospital, Medicine, Medical research, Diplomatic mission, LI, Freedom, MD, Physician, Feinstein Institute for Medical Research, First Nations in Ontario, Courage, Pharmaceutical industry, Warehouse, Online gambling, Northwell Health, Facebook

Standing before a large, hanging American flag, Northwell Health President and CEO Michael Dowling urged employees and friends of the health system to provide whatever assistance they could to ease the suffering of the people of Ukraine.

Key Points: 
  • Standing before a large, hanging American flag, Northwell Health President and CEO Michael Dowling urged employees and friends of the health system to provide whatever assistance they could to ease the suffering of the people of Ukraine.
  • He explained that Northwell, at the direction of Ukraines government, is sending a shipment of humanitarian aid that will be used to care for those injured during combat.
  • Northwell Health has established a Ukraine relief fund that will ultimately be directed to the health systems international relief partner Doctors Without Borders, and potentially others, as the specific needs of those affected become clearer.
  • Our 78,000 employees 18,900 nurses and 4,800 employed doctors, including members of Northwell Health Physician Partners are working to change health care for the better.

Feinstein Institutes Names Dr. Anil K. Malhotra Co-Director of the Institute of Behavioral Science

Retrieved on: 
星期四, 二月 10, 2022
Research, Mental Health, Hospitals, Genetics, Clinical Trials, Biotechnology, Pharmaceutical, Health, Science, Oncology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, American College of Neuropsychopharmacology, Neuroimaging, Multimedia, Northwell Health, National Institute, Lists of diseases, Medicine, Science, Faculty, National Institute of Mental Health, Research, Mental health, Medical research, Joel Elkes, Feinstein Institute for Medical Research, Schizophrenia, Gene, Behavior, GWAS, Risk, NIH, Technology, Behavioural sciences, Molecular medicine, National, Feinstein, Institute, Diagnosis, Credit, NIMH, CEO, Genetics, Psychiatry, Zucker Hillside Hospital, Genome-wide association study, Autoimmunity, Cornell University, Georgetown University, Pharmacogenomics, Wake Forest University, LinkedIn, Â, Hospital, Management, Pharmaceutical industry, Cancer, MD

The Feinstein Institutes for Medical Research , the research home of Northwell Health , has named Anil K. Malhotra, MD , co-director of the Institute of Behavioral Science .

Key Points: 
  • The Feinstein Institutes for Medical Research , the research home of Northwell Health , has named Anil K. Malhotra, MD , co-director of the Institute of Behavioral Science .
  • Dr. Malhotra, a Feinstein Institutes faculty member for nearly 15 years, currently serves as director of psychiatry research at Zucker Hillside Hospital , Northwells inpatient behavioral health facility in Queens.
  • View the full release here: https://www.businesswire.com/news/home/20220210005690/en/
    Anil K. Malhotra, MD, has been named the new co-director of the Institute of Behavioral Science at the Feinstein Institutes.
  • The Institute of Behavioral Science is one of five research institutes at the Feinstein Institutes, alongside Bioelectronic Medicine, Cancer, Health System Science and Molecular Medicine.

Northwell Health Event Provides Help for People, Communities Struggling With Substance Use Disorder

Retrieved on: 
星期三, 九月 1, 2021
General Health, Other Health, Health, Practice Management, Managed Care, People, Center, Northwell Health, Friends, Zucker Hillside Hospital, Twitter, Medicine, Instagram, Naloxone, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Medical research, Physician, CDC, Health, Feinstein Institute for Medical Research, Awareness, Hospital, Drug overdose, Multimedia, EAP, Head, Korea Disease Control and Prevention Agency, Patient, Nursing, LinkedIn, Table, Opioid epidemic, International Overdose Awareness Day, COVID-19, LCSW, MD, Health insurance, Pharmaceutical industry

View the full release here: https://www.businesswire.com/news/home/20210901005615/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210901005615/en/
    Employees at facilities throughout Northwell Health shared information about resources available to people impacted by substance use.
  • And by framing substance use as a medical issue like any other, we help lift the stigma that can close people off from seeking help.
  • We want our patients and our workforce to understand that no matter what their needs, help is available at Northwell.
  • Northwell Health is New York States largest health care provider and private employer, with 23 hospitals, 830 outpatient facilities and more than 16,600 affiliated physicians.